European committee takes a second look at Alzheimer’s drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
EU drugs regulator recommends Alzheimer's drug from Eisai-Biogen
The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...
CSR Wire4h
First Photorealistic AI Avatar for People Living With Alzheimer’s and Dementia Launched by Lenovo and Innovations in Dementia
The avatar was created from a composite of images of 10 people living with dementia and Alzheimer’s. From the initial pose of ...
The Lancet12h
Amyloid-lowering treatment in Alzheimer's disease
We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...
News Medical on MSN6h
BMI's influence on disease pathogenesis uncovered in new research
The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...
The New York Times17h
New York Times - Top Stories
Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...
Olympics22h
Olympic rings - Symbol of the Olympic Movement
“The Olympic symbol consists of five interlaced rings of equal dimensions (the Olympic rings), used alone, in one or in five different colours. When used in its five-colour version, these colours ...